{"entity":{"type":"insider","cik":"0001369806","url":"/insider/0001369806","json_url":"/insider/0001369806.json","name":"Fonstein Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":63,"n_filings":13,"first":"2009-08-25","last":"2012-03-20","span_basis":"filed_date"},"name_variants":[{"name":"Fonstein Michael","source":"filing","n_filings":13,"first_seen":"2009-08-25","last_seen":"2012-03-20"}],"transactions":[{"id":2717146,"accession":"0001171843-12-000978","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001171843-12-000978","line_url":"/filing/0001171843-12-000978#line-3","is_derivative":false,"issuer_cik":"0001318641","issuer_name":"CLEVELAND BIOLABS INC","issuer_ticker":"CBLI","issuer_name_source":null,"issuer_url":"/issuer/0001318641","owner_cik":"0001369806","owner_name":"Fonstein Michael","owner_display_name":"Fonstein Michael","owner_url":"/insider/0001369806","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock, par value $0.005 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":2.9448,"price_display":"2.94","price_state":"stated","total_value":58896.0,"total_display":"58,896.00","total_whole":"58,896","shares_owned_after":1168400.0,"shares_owned_after_display":"1,168,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-20","filed_date":"2012-03-20","scope":"insider"},{"id":2717140,"accession":"0001171843-12-000978","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001171843-12-000978","line_url":"/filing/0001171843-12-000978#line-2","is_derivative":false,"issuer_cik":"0001318641","issuer_name":"CLEVELAND BIOLABS INC","issuer_ticker":"CBLI","issuer_name_source":null,"issuer_url":"/issuer/0001318641","owner_cik":"0001369806","owner_name":"Fonstein Michael","owner_display_name":"Fonstein Michael","owner_url":"/insider/0001369806","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock, par value $0.005 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35601.0,"shares_display":"35,601","price_per_share":3.0404,"price_display":"3.04","price_state":"stated","total_value":108241.2804,"total_display":"108,241.28","total_whole":"108,241","shares_owned_after":1188400.0,"shares_owned_after_display":"1,188,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-19","filed_date":"2012-03-20","scope":"insider"},{"id":2717133,"accession":"0001171843-12-000978","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-12-000978","line_url":"/filing/0001171843-12-000978#line-1","is_derivative":false,"issuer_cik":"0001318641","issuer_name":"CLEVELAND BIOLABS INC","issuer_ticker":"CBLI","issuer_name_source":null,"issuer_url":"/issuer/0001318641","owner_cik":"0001369806","owner_name":"Fonstein Michael","owner_display_name":"Fonstein Michael","owner_url":"/insider/0001369806","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock, par value $0.005 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44399.0,"shares_display":"44,399","price_per_share":3.1225,"price_display":"3.12","price_state":"stated","total_value":138635.8775,"total_display":"138,635.88","total_whole":"138,636","shares_owned_after":1224001.0,"shares_owned_after_display":"1,224,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-16","filed_date":"2012-03-20","scope":"insider"},{"id":8922456,"accession":"0001144204-11-051465","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-11-051465","line_url":"/filing/0001144204-11-051465#line-1","is_derivative":false,"issuer_cik":"0001318641","issuer_name":"CLEVELAND BIOLABS INC","issuer_ticker":"CBLI","issuer_name_source":null,"issuer_url":"/issuer/0001318641","owner_cik":"0001369806","owner_name":"Fonstein Michael","owner_display_name":"Fonstein Michael","owner_url":"/insider/0001369806","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock, par value $0.005 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2200.0,"shares_display":"2,200","price_per_share":2.27,"price_display":"2.27","price_state":"stated","total_value":4994.0,"total_display":"4,994.00","total_whole":"4,994","shares_owned_after":1253400.0,"shares_owned_after_display":"1,253,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-02","filed_date":"2011-09-07","scope":"insider"},{"id":7300212,"accession":"0001144204-10-021793","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001144204-10-021793","line_url":"/filing/0001144204-10-021793","is_derivative":false,"issuer_cik":"0001318641","issuer_name":"CLEVELAND BIOLABS INC","issuer_ticker":"CBLI","issuer_name_source":null,"issuer_url":"/issuer/0001318641","owner_cik":"0001369806","owner_name":"Fonstein Michael","owner_display_name":"Fonstein Michael","owner_url":"/insider/0001369806","role":"Director, Officer (CEO, President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":3.949696,"price_display":"3.95","price_state":"stated","total_value":19748.48,"total_display":"19,748.48","total_whole":"19,748","shares_owned_after":1267700.0,"shares_owned_after_display":"1,267,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-04-22","filed_date":"2010-04-22","scope":"insider","n_lines":15},{"id":7404743,"accession":"0001144204-10-015179","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-10-015179","line_url":"/filing/0001144204-10-015179","is_derivative":false,"issuer_cik":"0001318641","issuer_name":"CLEVELAND BIOLABS INC","issuer_ticker":"CBLI","issuer_name_source":null,"issuer_url":"/issuer/0001318641","owner_cik":"0001369806","owner_name":"Fonstein Michael","owner_display_name":"Fonstein Michael","owner_url":"/insider/0001369806","role":"Director, Officer (CEO, President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":3.572604,"price_display":"3.57","price_state":"stated","total_value":17863.02,"total_display":"17,863.02","total_whole":"17,863","shares_owned_after":1272600.0,"shares_owned_after_display":"1,272,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-22","filed_date":"2010-03-23","scope":"insider","n_lines":5},{"id":7172236,"accession":"0001144204-10-009494","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-10-009494","line_url":"/filing/0001144204-10-009494","is_derivative":false,"issuer_cik":"0001318641","issuer_name":"CLEVELAND BIOLABS INC","issuer_ticker":"CBLI","issuer_name_source":null,"issuer_url":"/issuer/0001318641","owner_cik":"0001369806","owner_name":"Fonstein Michael","owner_display_name":"Fonstein Michael","owner_url":"/insider/0001369806","role":"Director, Officer (CEO, President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":3.8894,"price_display":"3.89","price_state":"stated","total_value":19447.0,"total_display":"19,447.00","total_whole":"19,447","shares_owned_after":1276200.0,"shares_owned_after_display":"1,276,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-22","filed_date":"2010-02-23","scope":"insider","n_lines":4},{"id":7334194,"accession":"0001144204-10-003402","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-10-003402","line_url":"/filing/0001144204-10-003402","is_derivative":false,"issuer_cik":"0001318641","issuer_name":"CLEVELAND BIOLABS INC","issuer_ticker":"CBLI","issuer_name_source":null,"issuer_url":"/issuer/0001318641","owner_cik":"0001369806","owner_name":"Fonstein Michael","owner_display_name":"Fonstein Michael","owner_url":"/insider/0001369806","role":"Director, Officer (CEO, President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":3.8618,"price_display":"3.86","price_state":"stated","total_value":19309.0,"total_display":"19,309.00","total_whole":"19,309","shares_owned_after":1281200.0,"shares_owned_after_display":"1,281,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-22","filed_date":"2010-01-25","scope":"insider","n_lines":5},{"id":7680938,"accession":"0001144204-10-000147","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-10-000147","line_url":"/filing/0001144204-10-000147","is_derivative":false,"issuer_cik":"0001318641","issuer_name":"CLEVELAND BIOLABS INC","issuer_ticker":"CBLI","issuer_name_source":null,"issuer_url":"/issuer/0001318641","owner_cik":"0001369806","owner_name":"Fonstein Michael","owner_display_name":"Fonstein Michael","owner_url":"/insider/0001369806","role":"Director, Officer (CEO, President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":951.0,"shares_display":"951","price_per_share":3.5605152471083072,"price_display":"3.56","price_state":"stated","total_value":3386.05,"total_display":"3,386.05","total_whole":"3,386","shares_owned_after":1286400.0,"shares_owned_after_display":"1,286,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-30","filed_date":"2010-01-04","scope":"insider","n_lines":2},{"id":6060018,"accession":"0001144204-09-066503","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-09-066503","line_url":"/filing/0001144204-09-066503#line-1","is_derivative":false,"issuer_cik":"0001318641","issuer_name":"CLEVELAND BIOLABS INC","issuer_ticker":"CBLI","issuer_name_source":null,"issuer_url":"/issuer/0001318641","owner_cik":"0001369806","owner_name":"Fonstein Michael","owner_display_name":"Fonstein Michael","owner_url":"/insider/0001369806","role":"Director, Officer (CEO, President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4049.0,"shares_display":"4,049","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":14171.5,"total_display":"14,171.50","total_whole":"14,172","shares_owned_after":1287151.0,"shares_owned_after_display":"1,287,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-23","filed_date":"2009-12-28","scope":"insider"},{"id":9235524,"accession":"0001144204-09-066495","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-09-066495","line_url":"/filing/0001144204-09-066495","is_derivative":false,"issuer_cik":"0001318641","issuer_name":"CLEVELAND BIOLABS INC","issuer_ticker":"CBLI","issuer_name_source":null,"issuer_url":"/issuer/0001318641","owner_cik":"0001369806","owner_name":"Fonstein Michael","owner_display_name":"Fonstein Michael","owner_url":"/insider/0001369806","role":"Director, Officer (CEO, President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":3.69,"price_display":"3.69","price_state":"stated","total_value":738.0,"total_display":"738.00","total_whole":"738","shares_owned_after":1291300.0,"shares_owned_after_display":"1,291,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-23","filed_date":"2009-12-28","scope":"insider","n_lines":2},{"id":5676731,"accession":"0001144204-09-061632","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001144204-09-061632","line_url":"/filing/0001144204-09-061632","is_derivative":false,"issuer_cik":"0001318641","issuer_name":"CLEVELAND BIOLABS INC","issuer_ticker":"CBLI","issuer_name_source":null,"issuer_url":"/issuer/0001318641","owner_cik":"0001369806","owner_name":"Fonstein Michael","owner_display_name":"Fonstein Michael","owner_url":"/insider/0001369806","role":"Director, Officer (CEO, President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":3.6106,"price_display":"3.61","price_state":"stated","total_value":18053.0,"total_display":"18,053.00","total_whole":"18,053","shares_owned_after":1291900.0,"shares_owned_after_display":"1,291,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-23","filed_date":"2009-11-23","scope":"insider","n_lines":8},{"id":6051683,"accession":"0001144204-09-054392","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001144204-09-054392","line_url":"/filing/0001144204-09-054392#line-7","is_derivative":false,"issuer_cik":"0001318641","issuer_name":"CLEVELAND BIOLABS INC","issuer_ticker":"CBLI","issuer_name_source":null,"issuer_url":"/issuer/0001318641","owner_cik":"0001369806","owner_name":"Fonstein Michael","owner_display_name":"Fonstein Michael","owner_url":"/insider/0001369806","role":"Director, Officer (CEO, President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1441.0,"shares_display":"1,441","price_per_share":4.16,"price_display":"4.16","price_state":"stated","total_value":5994.56,"total_display":"5,994.56","total_whole":"5,995","shares_owned_after":1296200.0,"shares_owned_after_display":"1,296,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-22","filed_date":"2009-10-23","scope":"insider"},{"id":6051679,"accession":"0001144204-09-054392","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-09-054392","line_url":"/filing/0001144204-09-054392#line-6","is_derivative":false,"issuer_cik":"0001318641","issuer_name":"CLEVELAND BIOLABS INC","issuer_ticker":"CBLI","issuer_name_source":null,"issuer_url":"/issuer/0001318641","owner_cik":"0001369806","owner_name":"Fonstein Michael","owner_display_name":"Fonstein Michael","owner_url":"/insider/0001369806","role":"Director, Officer (CEO, President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":4.2,"price_display":"4.20","price_state":"stated","total_value":5880.0,"total_display":"5,880.00","total_whole":"5,880","shares_owned_after":1298100.0,"shares_owned_after_display":"1,298,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-22","filed_date":"2009-10-23","scope":"insider"},{"id":6051676,"accession":"0001144204-09-054392","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-09-054392","line_url":"/filing/0001144204-09-054392#line-5","is_derivative":false,"issuer_cik":"0001318641","issuer_name":"CLEVELAND BIOLABS INC","issuer_ticker":"CBLI","issuer_name_source":null,"issuer_url":"/issuer/0001318641","owner_cik":"0001369806","owner_name":"Fonstein Michael","owner_display_name":"Fonstein Michael","owner_url":"/insider/0001369806","role":"Director, Officer (CEO, President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":4.22,"price_display":"4.22","price_state":"stated","total_value":2954.0,"total_display":"2,954.00","total_whole":"2,954","shares_owned_after":1300300.0,"shares_owned_after_display":"1,300,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-22","filed_date":"2009-10-23","scope":"insider"},{"id":6051673,"accession":"0001144204-09-054392","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-09-054392","line_url":"/filing/0001144204-09-054392#line-4","is_derivative":false,"issuer_cik":"0001318641","issuer_name":"CLEVELAND BIOLABS INC","issuer_ticker":"CBLI","issuer_name_source":null,"issuer_url":"/issuer/0001318641","owner_cik":"0001369806","owner_name":"Fonstein Michael","owner_display_name":"Fonstein Michael","owner_url":"/insider/0001369806","role":"Director, Officer (CEO, President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":4.21,"price_display":"4.21","price_state":"stated","total_value":2526.0,"total_display":"2,526.00","total_whole":"2,526","shares_owned_after":1299700.0,"shares_owned_after_display":"1,299,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-22","filed_date":"2009-10-23","scope":"insider"}],"collapsed":true,"next_cursor":"2009-10-22|6051673","ledger_fault":false,"count":{"value":63,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":62,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":63},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001318641","name":"CLEVELAND BIOLABS INC","url":"/issuer/0001318641","role":"Director, Officer (President)","n_filings":13,"first_seen":"2009-08-25","last_seen":"2012-03-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001369806","retrieved_at":"2026-08-27T04:54:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}